Inhaled Ciclesonide for Patients with Asthma or Chronic Obstructive Pulmonary Disease and COVID-19 - Reply

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{ab77860065884d6ea4089964260c019c,

title = "Inhaled Ciclesonide for Patients with Asthma or Chronic Obstructive Pulmonary Disease and COVID-19 - Reply",

author = "Clemency, \{Brian M.\} and Koster, \{David J.\} and Blaiss, \{Michael S.\}",

year = "2022",

month = may,

doi = "10.1001/jamainternmed.2022.0210",

language = "English",

volume = "182",

pages = "572",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "5",

}

TY - JOUR

T1 - Inhaled Ciclesonide for Patients with Asthma or Chronic Obstructive Pulmonary Disease and COVID-19 - Reply

AU - Clemency, Brian M.

AU - Koster, David J.

AU - Blaiss, Michael S.

PY - 2022/5

Y1 - 2022/5

UR - https://www.scopus.com/pages/publications/85127603707

U2 - 10.1001/jamainternmed.2022.0210

DO - 10.1001/jamainternmed.2022.0210

M3 - Letter

C2 - 35311914

AN - SCOPUS:85127603707

SN - 2168-6106

VL - 182

SP - 572

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

IS - 5

ER -